Cargando…

Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion

Detalles Bibliográficos
Autores principales:	Huang, Xiaoyuan, Bai, Xiangyang, Cao, Yang, Wu, Jingyi, Huang, Mei, Tang, Duozhuang, Tao, Si, Zhu, Tao, Liu, Yanling, Yang, Yang, Zhou, Xiaoxi, Zhao, Yanxia, Wu, Mingfu, Wei, Juncheng, Wang, Daowen, Xu, Gang, Wang, Shixuan, Ma, Ding, Zhou, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967912/ https://www.ncbi.nlm.nih.gov/pubmed/33720318 http://dx.doi.org/10.1084/jem.2009039703042021c

Ejemplares similares

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
por: Huang, Xiaoyuan, et al.
Publicado: (2010)

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2013)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Lymphoma: Immune Evasion Strategies
por: Upadhyay, Ranjan, et al.
Publicado: (2015)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Burkitt Lymphoma: Pathogenesis and Immune Evasion
por: God, Jason M., et al.
Publicado: (2010)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Zhang, Tingting, et al.
Publicado: (2020)

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018)

Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3(+) CD8(+) T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Zhang, Tingting, et al.
Publicado: (2021)

Simulated microgravity-mediated reversion of murine lymphoma immune evasion
por: Bradley, Jillian H., et al.
Publicado: (2019)

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium
por: Adams, R L, et al.
Publicado: (2005)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
por: de Charette, Marie, et al.
Publicado: (2018)

A Highly Curable Lymphoma Occurs Preferentially in the Proximal Tibia of Young Patients
por: Subik, M. Kristina, et al.
Publicado: (2014)

Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma
por: Gopalakrishnan, Ramakrishnan, et al.
Publicado: (2020)

GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma
por: Rong, Qi-xiang, et al.
Publicado: (2021)

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling
por: Zhang, Yang, et al.
Publicado: (2022)

Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion
por: Ye, Linsen, et al.
Publicado: (2018)

Clinicopathological Study of Sporadic Burkitt Lymphoma in Children
por: Huang, Hui, et al.
Publicado: (2015)

TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression
por: Hu, Tianyong, et al.
Publicado: (2017)

Preferential distribution of anionic sites on the basement membrane and the abluminal aspect of the endothelium in fenestrated capillaries
Publicado: (1982)

Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites
Publicado: (1981)

Extranodal NK/T-cell Lymphoma Mimicking Erythema Multiforme
por: Xia, Ying, et al.
Publicado: (2015)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
por: Chen, Rui, et al.
Publicado: (2022)

Overexpression of S100A9 in tumor stroma contribute to immune evasion of NK/T cell lymphoma and predict poor response rate
por: Zhou, Zhiyuan, et al.
Publicado: (2021)

Mertk Interacts with Tim-4 to Enhance Tim-4-Mediated Efferocytosis
por: Moon, Byeongjin, et al.
Publicado: (2020)

Trans‐homophilic interaction of CADM1 promotes organ infiltration of T‐cell lymphoma by adhesion to vascular endothelium
por: Kasai, Yutaka, et al.
Publicado: (2022)

Radiation Pneumonitis after Radiotherapy of Neck Lymphoma
por: Wei, Min, et al.
Publicado: (2014)

The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
por: Zhou, Tianlin, et al.
Publicado: (2020)

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
por: Wu, Jiaying, et al.
Publicado: (2022)

Innate Immune Evasion of Alphaherpesvirus Tegument Proteins
por: Yang, Linjiang, et al.
Publicado: (2019)

High-Frequency Homologous Recombination Occurred Preferentially in Populus
por: Geng, Xining, et al.
Publicado: (2021)

Circulating PD‐1 (+) cells may participate in immune evasion in peripheral T‐cell lymphoma and chidamide enhance antitumor activity of PD‐1 (+) cells
por: Zhang, Wei, et al.
Publicado: (2019)

Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B‐cell Lymphoma and NK/T‐cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2023)

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
por: Plaks, Vicki, et al.
Publicado: (2021)

SARS‐CoV‐2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion
por: Quaglia, Federica, et al.
Publicado: (2022)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer
por: Wang, Xin, et al.
Publicado: (2022)

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma
por: Chen, Benjamin J., et al.
Publicado: (2019)

Systematic Oxidative Stress Indexes Associated with the Prognosis in Patients with T Lymphoblastic Lymphoma/Leukemia
por: Ping, Liqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cqdops96mv1ur1pe37cck4lvqj